Arbutus Biopharma Corporation
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-67.5M | $-68.3M | $809.0K | $6.4M |
| FY2022 | $-35.4M | $-35.9M | $512.0K | $7.2M |
| FY2023 | $-85.9M | $-86.9M | $1.0M | $9.3M |
| FY2024 | $-64.9M | $-65.0M | $182.0K | $9.0M |
| FY2025 | $-39.6M | $-39.6M | $0 | $7.0M |